Camstent today announced that Joe Byrne has joined the company as Chief Operating Officer (COO). Joe will be responsible for overseeing the scale up of Camstent’s operations ahead of receiving regulatory approval for the company’s first product, the Camstent Foley Catheter, in Q4 2016. Camstent recently opened its first manufacturing facility as it prepares for product launch.
Joe joins from fibre optic cable manufacturer m2fx, now part of the PPC division of Belden, Inc. As m2fx Chief Financial Officer, Joe played a lead role in growing the business from a start-up to its sale to Belden in early 2016. As well as financial management, including fundraising, Joe was also responsible for global marketing and African business development for the company. During his time m2fx sales grew from an annual run rate of £1m to £9m. Prior to m2fx Joe held senior leadership roles at thermal management start-up Cambridge Nanotherm, Vodafone Ghana, CBNL and surface coating company Keronite.
“What attracted me to Camstent was the huge potential for its bacteria-phobic coatings in the medical device market,” said Joe Byrne, Chief Operating Officer, Camstent. “38% of all hospital acquired infections come from bacterial infections of catheters alone – Camstent’s revolutionary technology has the ability to reduce this dramatically, saving lives and increasing efficiency for healthcare providers. I’m looking forward to helping Camstent as it expands and moves forward with the launch of its first product later in the year.”
In a further move to strengthen Camstent’s board, Christopher Kingsman of Greenwood Investments has joined as a non-executive director. He brings over 15 years of research, investment and trading experience to Camstent, and has a particular focus on helping emerging companies to grow and realise their potential.